Robotic Coronary Anastomosis for Beating-Heart Surgery: A Contemporary Review

Abstract

Robotic coronary anastomosis on the beating heart represents a paradigm shift in coronary artery bypass grafting (CABG), offering a minimally invasive alternative to conventional techniques. This review synthesizes current evidence on the clinical efficacy, technical considerations, and outcomes of robotic-assisted coronary anastomosis performed without cardiopulmonary bypass. Drawing upon PubMed-indexed studies and recent clinical guidelines, the article explores epidemiology, pathophysiology, risk factors, diagnosis, management, and emerging therapies, aiming to provide clinicians with a comprehensive understanding of this rapidly evolving field.

Introduction

Coronary artery disease (CAD) remains a leading cause of morbidity and mortality worldwide, necessitating continual evolution in revascularization strategies. Traditional CABG has long been the gold standard for multi-vessel and complex coronary disease; however, its invasiveness and associated morbidity have fueled the search for less traumatic alternatives. Robotic coronary anastomosis performed on the beating heart leverages advanced robotic systems to facilitate precise, minimally invasive grafting without the need for cardiopulmonary bypass. This review critically examines the scientific underpinnings, clinical outcomes, and future potential of robotic beating-heart coronary anastomosis.

Epidemiology / Disease Burden

Globally, an estimated 126 million individuals suffer from ischemic heart disease, with CAD accounting for over 9 million deaths annually. CABG remains a cornerstone in the management of severe CAD, with more than 400,000 procedures performed annually in the United States alone. Despite advances in percutaneous interventions, revascularization through CABG remains essential, particularly in patients with multi-vessel or left main disease. The burden of postoperative complications, prolonged recovery, and resource utilization associated with conventional CABG underscores the clinical impetus for minimally invasive, robotic-assisted approaches.

Pathophysiology

CAD arises from atherosclerotic plaque deposition within coronary arteries, leading to progressive luminal narrowing, myocardial ischemia, and risk of infarction. The pathophysiological rationale for surgical revascularization is to restore coronary blood flow beyond critical stenoses, preserve myocardial viability, and improve clinical outcomes. Traditional CABG achieves this via saphenous vein or arterial grafts, typically requiring cardiac arrest and cardiopulmonary bypass. Beating-heart (off-pump) techniques avoid the deleterious effects of extracorporeal circulation, such as systemic inflammation and coagulopathy, while robotics enable enhanced precision and visualization during anastomosis.

Risk Factors

Patient selection for robotic beating-heart coronary anastomosis must consider both general and procedure-specific risk factors. General CAD risk factors include hypertension, diabetes mellitus, dyslipidemia, smoking, family history, and sedentary lifestyle. Procedural risk factors unique to robotic-assisted surgery encompass anatomical variations, severe calcification, small target vessels, and prior thoracic surgery. Optimal patient selection is paramount, with current guidelines favoring patients with isolated left anterior descending (LAD) disease and preserved ventricular function for robotic approaches.

Clinical Features

Patients with significant CAD typically present with exertional angina, dyspnea, reduced exercise tolerance, or acute coronary syndromes. In clinical practice, those considered for robotic beating-heart procedures often have stable CAD, suitable anatomy for minimally invasive access, and an elevated risk profile for sternotomy or cardiopulmonary bypass. Notably, robotic-assisted surgery may reduce postoperative pain, infection rates, and recovery time, thereby enhancing the overall patient experience.

Diagnosis

Accurate diagnosis and anatomical delineation are critical for procedural planning. Non-invasive modalities such as stress echocardiography, myocardial perfusion imaging, and coronary computed tomography angiography (CTA) are instrumental in identifying ischemia and guiding revascularization. Invasive coronary angiography remains the gold standard for defining coronary anatomy and lesion severity. Preoperative imaging must assess suitability for minimally invasive access, target vessel quality, and the feasibility of robotic instrumentation.

Treatment & Management

Beating-heart robotic coronary anastomosis is performed via small thoracic ports, utilizing specialized robotic arms and high-definition three-dimensional visualization. The most common application is the totally endoscopic coronary artery bypass (TECAB), frequently targeting the LAD with an internal mammary artery graft. Key steps include precise vessel stabilization, intrathoracic anastomosis using micro-instruments, and intraoperative assessment of graft patency. Compared to traditional CABG, the robotic approach minimizes surgical trauma, eliminates sternotomy, and avoids cardiopulmonary bypass-associated complications. Postoperative care emphasizes early mobilization, pain control, and vigilant monitoring for graft occlusion or arrhythmias.

Recent Advances / Emerging Therapies

Recent innovations in robotics have refined the precision, reproducibility, and safety of beating-heart anastomosis. Enhanced robotic platforms offer improved dexterity, tremor filtration, and real-time imaging integration. Adjunctive technologies such as intraoperative fluorescence angiography and transit-time flow measurement facilitate immediate verification of graft integrity. Hybrid coronary revascularization, combining robotic arterial grafting with percutaneous coronary intervention (PCI) to non-LAD vessels, represents a promising strategy for select patients. Ongoing trials are evaluating novel sutureless anastomotic devices and fully automated robotic systems with artificial intelligence integration, which may further broaden procedural indications and improve outcomes.

Guideline Recommendations

Current guidelines from the American Heart Association (AHA), American College of Cardiology (ACC), and European Society of Cardiology (ESC) recognize minimally invasive and robotic-assisted CABG as viable alternatives to conventional surgery in appropriately selected patients. The recommendations emphasize the importance of institutional experience, dedicated surgical teams, and rigorous patient selection criteria. While evidence supports the safety and efficacy of robotic beating-heart anastomosis for isolated LAD disease, further randomized trials are needed to define its role in multi-vessel revascularization and high-risk cohorts. Multidisciplinary heart team discussions remain essential for individualized treatment planning.

Conclusion

Robotic coronary anastomosis for beating-heart surgery embodies a significant advance in surgical revascularization, offering a less invasive option with favorable perioperative outcomes in selected patients. The approach combines the physiologic benefits of off-pump techniques with the technical precision of robotics, resulting in reduced morbidity and faster recovery. Continued technological innovation, rigorous training, and evidence generation will be fundamental to broader adoption and optimization of this technique. For clinicians, a nuanced understanding of patient selection, technical nuances, and evolving guidelines is crucial to harness the full potential of robotic beating-heart CABG in contemporary practice.